RA PHARMACEUTICALS, INC. Operating Expenses
RA PHARMACEUTICALS, INC. reported Operating Expenses of $37.83 million for the 3-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2020-02-27
- RA PHARMACEUTICALS, INC. operating expenses for the quarter ending 2019-12-31 was $37.83M, a 97.45% increase year-over-year.
- RA PHARMACEUTICALS, INC. operating expenses for the quarter ending 2019-09-30 was $29.22M, a 73.09% increase year-over-year.
- RA PHARMACEUTICALS, INC. operating expenses for the quarter ending 2019-06-30 was $22.85M, a 41.68% increase year-over-year.
- RA PHARMACEUTICALS, INC. operating expenses for the quarter ending 2019-03-31 was $20.09M, a 20.12% increase year-over-year.
- RA PHARMACEUTICALS, INC. operating expenses for fiscal 2019 was $109.98M, a 59.65% increase from fiscal 2018.
- RA PHARMACEUTICALS, INC. operating expenses for fiscal 2018 was $68.89M, a 25.18% increase from fiscal 2017.
- RA PHARMACEUTICALS, INC. operating expenses for fiscal 2017 was $55.03M, a 67.00% increase from fiscal 2016.
- RA PHARMACEUTICALS, INC. operating expenses for fiscal 2016 was $32.95M, a 88.84% increase from fiscal 2015.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2019-12-31 | $37.83M 10-K · filed 2020-02-27 | $67.04M derived: sum of 2 quarters · filed 2020-02-27 | $89.89M derived: sum of 3 quarters · filed 2020-02-27 | $109.98M 10-K · filed 2020-02-27 |
| 2019-09-30 | $29.22M 10-K · filed 2020-02-27 | $52.06M derived: sum of 2 quarters · filed 2020-02-27 | $72.15M 10-Q · filed 2019-11-07 | $91.31M derived: sum of 4 quarters · filed 2020-02-27 |
| 2019-06-30 | $22.85M 10-K · filed 2020-02-27 | $42.94M 10-Q · filed 2019-08-07 | $62.09M derived: sum of 3 quarters · filed 2020-02-27 | $78.97M derived: sum of 4 quarters · filed 2020-02-27 |
| 2019-03-31 | $20.09M 10-K · filed 2020-02-27 | $39.25M derived: sum of 2 quarters · filed 2020-02-27 | $56.13M derived: sum of 3 quarters · filed 2020-02-27 | $72.25M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-12-31 | $19.16M 10-K · filed 2020-02-27 | $36.04M derived: sum of 2 quarters · filed 2020-02-27 | $52.16M derived: sum of 3 quarters · filed 2020-02-27 | $68.89M 10-K · filed 2020-02-27 |
| 2018-09-30 | $16.88M 10-K · filed 2020-02-27 | $33.01M derived: sum of 2 quarters · filed 2020-02-27 | $49.73M 10-Q · filed 2019-11-07 | $65.05M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $16.13M 10-K · filed 2020-02-27 | $32.85M 10-Q · filed 2019-08-07 | $48.17M derived: sum of 3 quarters · filed 2020-02-27 | $63.59M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $16.72M 10-K · filed 2020-02-27 | $32.05M derived: sum of 2 quarters · filed 2020-02-27 | $47.46M derived: sum of 3 quarters · filed 2020-02-27 | $60.27M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $15.32M 10-K · filed 2019-03-07 | $30.74M derived: sum of 2 quarters · filed 2019-03-07 | $43.55M derived: sum of 3 quarters · filed 2019-03-07 | $55.03M 10-K · filed 2019-03-07 |
| 2017-09-30 | $15.41M 10-K · filed 2019-03-07 | $28.23M derived: sum of 2 quarters · filed 2019-03-07 | $39.71M 10-Q · filed 2018-11-07 | $50.70M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | $12.81M 10-K · filed 2019-03-07 | $24.29M 10-Q · filed 2018-08-08 | $35.29M derived: sum of 3 quarters · filed 2019-03-07 | $43.41M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | $11.48M 10-K · filed 2019-03-07 | $22.47M derived: sum of 2 quarters · filed 2019-03-07 | $30.59M derived: sum of 3 quarters · filed 2019-03-07 | $38.19M derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | $10.99M 10-K · filed 2018-03-14 | $19.11M derived: sum of 2 quarters · filed 2018-03-14 | $26.70M derived: sum of 3 quarters · filed 2018-03-14 | $32.95M 10-K · filed 2018-03-14 |
| 2016-09-30 | $8.12M 10-K · filed 2018-03-14 | $15.71M derived: sum of 2 quarters · filed 2018-03-14 | $21.96M 10-Q · filed 2016-11-29 | $27.27M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | $7.59M 10-K · filed 2018-03-14 | $13.84M derived: sum of 2 quarters · filed 2018-03-14 | $19.15M derived: sum of 3 quarters · filed 2018-03-14 | $23.71M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | $6.25M 10-K · filed 2018-03-14 | $11.56M derived: sum of 2 quarters · filed 2018-03-14 | $16.12M derived: sum of 3 quarters · filed 2018-03-14 | $19.89M derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | $5.31M 10-K · filed 2017-03-06 | $9.87M derived: sum of 2 quarters · filed 2017-03-06 | $13.65M derived: sum of 3 quarters · filed 2017-03-06 | $17.45M 10-K · filed 2018-03-14 |
| 2015-09-30 | $4.57M 10-K · filed 2017-03-06 | $8.34M derived: sum of 2 quarters · filed 2017-03-06 | $12.14M 10-Q · filed 2016-11-29 | |
| 2015-06-30 | $3.77M 10-K · filed 2017-03-06 | $7.58M derived: sum of 2 quarters · filed 2017-03-06 | ||
| 2015-03-31 | $3.80M 10-K · filed 2017-03-06 | |||
| 2014-12-31 | $11.94M 10-K · filed 2017-03-06 |